Poliovirus immunity among pregnant females aged 15-44 Years, Namibia, 2010

Journal of Infectious Diseases

Volumn 210, Issue , 2014, Pages S136-S142

  Cardemil, Cristina V ^a   Jonas, Anna ^b   Gerber, Sue ^a   Weldon, William C ^a   Steven Oberste, M ^a   Beukes, Anita ^a   Sawadogo, Souleymane ^a   Patel, Sadhna V ^a   Zeko, Sikota ^b   Muroua, Clementine ^b   Gaeb, Esegiel ^c   Wannemuehler, Kathleen ^a   Goodson, James L ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Min of Health and Social Services   (Namibia)

^c Namibia Institute of Pathology   (Namibia)

Author keywords

adults; HIV; Namibia; neutralizing antibody; OPV; polio; poliovirus; population immunity; pregnant women; seroprevalence

Indexed keywords

NEUTRALIZING ANTIBODY; POLIOMYELITIS VACCINE; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE; ANTIVIRAL THERAPY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; IMMUNITY; INFECTION RISK; MAJOR CLINICAL STUDY; NAMIBIA; NONHUMAN; POLIOMYELITIS VIRUS; POLIOMYELITIS VIRUS 1; POLIOVIRUS TYPE 2; POLIOVIRUS TYPE 3; PREGNANT WOMAN; REVIEW; RISK ASSESSMENT; SEROPREVALENCE; TREND STUDY; YOUNG ADULT; BLOOD; EPIDEMIC; EPIDEMIOLOGY; IMMUNOLOGY; POLIOMYELITIS; PREGNANCY; UTILIZATION; VACCINATION;

ADOLESCENT; ADULT; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; DISEASE OUTBREAKS; FEMALE; HUMANS; NAMIBIA; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINES; PREGNANCY; SEROEPIDEMIOLOGIC STUDIES; VACCINATION; YOUNG ADULT;

EID: 84910594065     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu086     Document Type: Review

References (37)

1. Global Polio Erad ication Initiative. Data and monitoring: wild poliovirus cases. http://www.polioeradication.org/Dataandmonitoring/Poliothisweek.aspx. Accessed 20 December 2013.
2. Centers for Disease Control and Prevention. Outbreaks foll owing wild poliovirus importations-Europe, Africa, and Asia, January 2009-September 2010. Morb Mortal Wkly Rep 2010; 59:1393-9.
3. Centers for Disease Control and Prevention. Notes from the field: poliomyelitis outbreak-republic of the Congo, September 2010-February 2011. Morb Mortal Wkly Rep 2011; 60:312-3.
4. Patel MK, Konde MK, Didi-Ngossaki BH, et al. An outbreak of wild poliovirus in the Republic of Congo, 2010-2011. Clin Infect Dis 2012; 55:1291- 8.
5. Namibia Housing and Population Census. http://www.paris21.org/sites/default/files/825.pdf. Accessed 20 December 2013.
6. World He alth Organization-Namibia. 2011 annual report. Geneva: WHO, 2012.
7. Namibia Demographic and Health Survey 2006- 07. http://www.measuredhs.com/countries/country-main.cfm?ctry-id=28&c=Namibia. Accessed 20 December 2013.
8. UNAIDS Country Reports HIV and AIDS estimates 2012: Namibia. http://www.unaids.org/en/Regionscountries/Countries/Namibia/. Accessed 6 December 2013.
9. AIDSinfo [database online]. http://www.aidsinfoonline.org/devinfo/libraries/aspx/Home.aspx. Accessed 20 December 2013.
10. WHO Vaccine-Preventable Diseases Monitoring System. 2013 global summary, Namibia. http://apps.who.int/immunization-monitoring/globalsummary/countries?countrycriteria%5Bcountry%5D%5B%5D=NAM&commit=OK. Accessed 20 December 2013.
11. Yusuf N, de Wee R, Forster N, et al. Outbreak of type 1 wild poliovirus in adults, Namibia, 2006. J Infect Dis 2014; 210(suppl 1):S353-60.
12. Centers for Disea se Control and Prevention. Outbreak of polio in adults-Namibia, 2006. MMWR Morb Mortal Wkly Rep 2006; 55:1198-201.
13. Kä rber G, Beitrag zur kollektiven. Behandlung pharmakologischer Reihenversuche. Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie 162:480-483.
14. Kidd S, Goodson JL, Aramburu J, et al. Poliomyelitis outbreaks in Angola genetically linked to India: Ri sk factors and implications for prevention of outbreaks due to wild poliovirus importations. Vaccine 2011; 29:3760-6.
15. World Health Organization. Conclusions and recommendations of the Advisory Committe on Poliomyelitis Eradication. Wkly Epidemiol Rec 2010; 85:1-11.
16. UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. Guidelines for Conducting HIV Sentinel Serosurveys among Pregnant Wome n and Other Groups. http://data.unaids.org/Publications/IRC-pub06/jc954-Anc-serosurveys-guidelines-en.pdf. Accessed 20 December 2013.
17. Report on the 2010 National HIV Sentinel Survey: HIV prevalence rate in pregnant woman, biannu al survey 1992-2010, Namibia. Windhoek: Ministry of Health and Social Services, Republic of Namibia, 2010. http://www.mhss.gov.na/documents/hiv-Aids/National%20HIV%20Sentinel%20Survey%202010.pdf. Accessed 20 December 2013.
18. World Health Organization. Manual for the virological investigation of polio. EPI/GEN/97.01.EPV1. Geneva: World Health Organization, 1997.
19. Report of a WHO informal consultation on polio neutralization antibody assays, Nashville, 5-6 December 1991. WHO/EPI/RD/91.3 Rev. Geneva: World Health Organization. 1991.
20. Kä rber G. Archiv fuer experimentelle pathologie und pharmakologie 1931; 162:480-3.
21. Affanni P, Veronesi L, Rizziero S, et al. Status of immunity against poliomyelitis: a study among European and extra-European young immigrants living in Parma. Acta Biomed 2 005; 76:157-63.
22. Calderon-Margalit R, Sofer D, Gefen D, et al. Immune status to poliovirus among immigrant workers in Israel. Prev Med 2005; 40: 685-9.
23. Baldo V, Baldovin T, Cocchio S, et al. Seroepidemiology of polioviruses among university students in northern Italy. Clin Vaccine Immunol 2012; 19:1292-5.
24. de Melker HE, van den Hof S, Berbers GA, et al. Evaluation of the national immunisation programme in the Netherlands: immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella and Haemophilus influenzae type b. Vaccine 2003; 21:716-20.
25. Frantzidou F, Diza E, Halkia D, Antoniadis A. A seroprevalence study of poliovirus antibody in the population of northern Greece. Clin Microbiol Infect 2005; 11:68-71.
26. Pires de Miranda M, Carmo Gomes M, Rebelo de Andrade H. Seroprevalence of antibodies to poliovirus in individuals living in Portugal, 2002. Euro Surveill 2007; 12:E7-8.
27. Signo rini L, Barbi M, Matteelli A, et al. Prevalence of anti-poliovirus type 1, 2 and 3 antibodies in unvaccinated Italian travelers. J Travel Med 2004; 11:34-6.
28. Wicker S, Rabenau HF, Gott schalk R, et al. Seroprevalence of vaccine preventable and blood transmissible viral infections (measles, mumps, rubella, polio, HBV, HCV and HIV) in medical students. Med Microbiol Immunol 2007; 196:145-50.
29. Pí rez MC, Olivera I, Diabarboure H, et al. Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategies. Vaccine 2009; 27:2689-94.
30. Sutter RW, Kew O, Cochi SL. Poliovirus vaccine-live. In: Plotkin SA, OrensteinWA, eds. Vaccines. 4th ed, ch 26. Philadelphia:W. B. Saunders, 2004.
31. Sutter RW, Patriarc a PA, Cochi SL, et al. Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet 1991;338:715-20.
32. Pregliasco F, Minolfi V, Boschin A, et al. A seroepidemiologic survey of immunity against poliomyelitis in a group of HIV positive and HIV negative drug addicts. Eur J Epidemiol 1995; 11:693-5.
33. Gnanashanmugam D, Troy SB, Musingwini G, et al. Immunologic response to oral polio vaccine in human immunodeficiency virus-infected and uninfected Zimbabwean children. Pediatr Infect Dis J 2012; 31:176-80.
34. Troy SB, M usingwini G, Halpern MS, et al. Vaccine poliovirus shedding and immune response to oral polio vaccine in HIVinfected and-uninfected Zimbabwean infants. J Infect Dis 2013; 208:672-8.
35. Khetsuriani N, Helfand R, Pallansch M, et al. Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya. BMC Infect Dis 2009. http://www.biomedcentral.com/conten t/p.df/1471-2334-9-136.pdf.
36. Meeting of the Strategic Advisory Group of Experts on Immunization, April 2012-conclusions and recommendations. Wkly Epidemiol Rec 2012; 87:201-16. http://wwwwhoint/wer.
37. Global Polio Er adication Initiative. Polio Eradication and Endgame Strategic Plan: 2013- 2018, 2013. http://wwwpolioeradicationorg/Portals/0/Document/Resources/StrategyWork/EndgameStratPlan-20130409-ENGpdf. Accessed 6 December 2013.